Skip to main content
. Author manuscript; available in PMC: 2018 May 23.
Published in final edited form as: Cancer Biol Ther. 2009 Nov 7;8(22):2136–2143. doi: 10.4161/cbt.8.22.9743

Figure 2.

Figure 2

GSI treatment resulted in prominent necrosis of KSHV-positive lymphomas. (A) Tumor growth post BJAB, BCBL1, JSC1 cell transplantation in PEL/SCID mice. Tumor size of BJAB cell transplantation between GSItreated and mock-treated groups had no difference, and exhibited no cell necrosis in tumor tissues; however, tumor tissues of KSHV-positive both BCBL1 and JSC1 cell transplantation with GSI-treated group showed prominent necrosis (arrowed) (HE staining, low magnification). (B) Tumor cell growth of BJAB cell transplantation with GSI-treated and mock-treated groups were good, whereas tumors of BCBL1, JSC1 cell transplantation with GSI treatment group had prominent necrosis (HE stain ×400).